Generic error message for required data elements: Data value required for tag <Data Element Number>,,,,,,,,
Generic error message for incorrect Observation Code Values: <Data Element Number> contains invalid value <value>,,,,,,,,
Generic error message for incorrect Max length: Maximum length exceeds for tag <Data Element Number>,,,,,,,,
Generic error message for future Date and Time: <Data Element Number> contains Future date,,,,,,,,
Generic error message for inpresise Date and Time: <Data Element Number> does not contain minimum precision of “CCYYMMDD”,,,,,,,,
Generic error message for inpresise full Date and Time: <Data Element Number> does not contain full precision date,,,,,,,,
DATA ELEMENT NUMBER,DATA ELEMENT NAME,BUSINESS RULE,"REJECTION, IF NOT MET","WARNING, IF NOT MET",ERROR ID,ERROR DESCRIPTION,,
(Header),ICH CSR Transmission Identification (batch wrapper),,,,,,,
N.1.1,Types of Message in batch,,,,,,,
N.1.2,Batch Number,,,,,,,
N.1.3,Batch Sender Identifier,,,,,,,
N.1.4,Batch Receiver Identifier,"For ICSR sent to the postmaket route use the value ""ZZFDA"". ",ü,,R0004,"ICSR sent to the postmaket route does not have the value ""ZZFDA"" for N.1.4",,
,,"For ICSR sent to the premaket route use the value ""ZZFDA_PREMKT"".",ü,,R0005,"ICSR sent to the premaket route does not have the value ""ZZFDA_PREMKT"" for N.1.4",,
N.1.5,Date of Batch Transmission,,,,,,,
(Header),ICH ICSR Message Header (message wrapper) (Repeat as necessary),,,,,,,
N.2.r.1 ,Message Identifier,,,,,,,
N.2.r.2 ,Message Sender Identifier,,ü,,R0100,N.2.r.2 provided is not same for all reports and does not match with N.1.3,,
N.2.r.3 ,Message Receiver Identifier,"For postmarket ICSRs
Use the value ""CDER"". If Batch Receiver Identifier (N.1.4) = ""ZZFDA"", then Message Receiver Identifier (N.2.r.3) must be 'CDER' ",ü,,R0006,"N.1.4 = ""ZZFDA"" but N.2.r.3 is not ""CDER""",,
,,"For premarket ICSRs
For CDER IND use the value ""CDER_IND"" or
For CBER IND use the value ""CBER_IND"" or
For CDER IND-exempt BA/BE use the value  ""CDER_IND_EXEMPT_BA_BE""

If Batch Receiver Identifier (N.1.4) = ""ZZFDA_PREMKT"", then Message Receiver Identifier (N.2.r.3) must be either 'CDER_IND' or 'CBER_IND' or 'CDER_IND_EXEMPT_BA_BE'",ü,,R0007,"N.1.4 = ""ZZFDA_PREMKT"" but N.2.r.3 is not ""CDER_IND"" or ""CBER_IND"" or ""CDER_IND_EXEMPT_BA_BE""",,
N.2.r.4 ,Date of Message Creation,,,,,,,
(Header),Identification of the Case Safety Report,,,,,,,
C.1.1 ,Sender’s (case) Safety Report Unique Identifier,,,,,,,
C.1.2 ,Date of Creation,,,,,,,
C.1.3 ,Type of Report,"If Batch Receiver Identifier (N.1.4) = ZZFDA_PREMKT and Message Receiver Identifier (N.2.r.3) = 'CDER_IND' or 'CBER_IND' or 'CDER_IND_EXEMPT_BA_BE' and (IND Number where AE Occurred (FDA.C.5.5a) or Pre-ANDA Number where AE Occurred (FDA.C.5.5b)) is provided and Study Type Where Reaction(s) / Event(s) Were Observed (C.5.4) = (1, 2 or 3) then Type of Report (C.1.3) must be 2=Report from Study",ü,,R0008,"C.1.3 must be 2 when N.1.4 = ""ZZFDA_PREMKT"" and N.2.r.3 = 'CDER_IND' or 'CBER_IND' or 'CDER_IND_EXEMPT_BA_BE' and (FDA.C.5.5a or FDA.C.5.5b) is provided and C.5.4 = (1, 2 or 3)  ",,
,,If Batch Receiver Identifier (N.1.4) = ZZFDA_PREMKT and Message Receiver Identifier (N.2.r.3) = 'CDER_IND' or 'CBER_IND' and IND Number where AE Occurred (FDA.C.5.5a) is provided and Study Type Where Reaction(s) / Event(s) Were Observed (C.5.4) is not provided then Type of Report (C.1.3) must be 1=Spontaneous,ü,,R0110,"C.1.3 must be 1 when N.1.4 = ""ZZFDA_PREMKT"" and N.2.r.3 = ('CDER_IND' or 'CBER_IND') and FDA.C.5.5a is provided and C.5.4 is not provided",,
,,"If Batch Receiver Identifier (N.1.4) = ZZFDA_PREMKT and Message Receiver Identifier (N.2.r.3) = ""CDER_IND_EXEMPT_BA_BE"" then C.1.3 must be 2 (Clinical trail).",ü,,R0111,"C.1.3 must be 2 when N.1.4 = ""ZZFDA_PREMKT"" and N.2.r.3 = 'CDER_IND_EXEMPT_BA_BE' ",,
,,If Batch Receiver Identifier (N.1.4) = ZZFDA_PREMKT and Message Receiver Identifier (N.2.r.3) = 'CDER_IND' or 'CBER_IND' then C.1.3 must not be (3 (Other) or 4 (Not available to sender (unknown)).,ü,,R0112,"C.1.3 must not be 3 or 4 when N.1.4 = ""ZZFDA_PREMKT"" and N.2.r.3 = 'CDER_IND' or 'CBER_IND'",,
C.1.4 ,Date Report Was First Received from Source,,,,,,,
C.1.5,Date of Most Recent Information for This Report,,,,,,,
(Header),Additional Available Documents Held by Sender,,,,,,,
C.1.6.1,Are Additional Documents Available?,,,,,,,
(Header),Documents Held by Sender (repeat as necessary),,,,,,,
C.1.6.1.r.1,Documents Held by Sender,"Optional, but required if C.1.6.1 is ‘true’.",ü,,R0009,C.1.6.1.r.1 must be provided when C.1.6.1 = true,,
C.1.6.1.r.2,Included Documents,Compression is not used for US reporting and encoding is limited to B64. ,ü,,R0010,Compression used for US reporting and encoding is not B64. ,,
C.1.7 ,Does This Case Fulfil the Local Criteria for an Expedited Report?,FDA does not support use of the nullFlavor 'NI' for this data element in initial submissions. Initial submissions with nullFlavor NI will be rejected.,ü,,R0011,nullFlavor 'NI' used for initial report submission,,
FDA.C.1.7.1,Local Criteria Report Type,"For postmarket ICSRs
If Combination Product Report Indicator (FDA.C.1.12) = True and Does This Case Fulfil the Local Criteria for an Expedited Report? (C.1.7) = True, Observation Code: (Value allowed: 1, 4)",ü,,R0012,FDA.C.1.7.1 must have Observation Code Value of 1 or 4 when FDA.C.1.12 = true and C.1.7 = true,,
,,"For postmarket ICSRs
If Combination Product Report Indicator (FDA.C.1.12) = True and Does This Case Fulfil the Local Criteria for an Expedited Report? (C.1.7) = False or NI, Observation Code: (Value allowed: 2, 5)",ü,,R0013,"FDA.C.1.7.1 must have Observation Code Value of 2 or 5 when FDA.C.1.12 = true and C.1.7 = false or nullFlavor ""NI"" ",,
,,"For postmarket ICSRs
If Combination Product Report Indicator (FDA.C.1.12) = False or NI and Does This Case Fulfil the Local Criteria for an Expedited Report? (C.1.7) = True, Observation Code: (Value allowed: 1) ",ü,,R0014,FDA.C.1.7.1 must have Observation Code Value of 1 when FDA.C.1.12 = false or NI and C.1.7 = true,,
,,"For postmarket ICSRs
If Combination Product Report Indicator (FDA.C.1.12) = False or NI and Does This Case Fulfil the Local Criteria for an Expedited Report? (C.1.7) = False or NI, Observation Code: (Value allowed: 2)",ü,,R0015,"FDA.C.1.7.1 must have Observation Code Value of 2 when FDA.C.1.12 = false or nullFlavor ""NI"" and C.1.7 = false or nullFlavor ""NI"" ",,
,,"For premarket ICSRs
For 15-Day or 7-Day Expedited report, if Does This Case Fulfil the Local Criteria for an Expedited Report? (C.1.7) = True and Type of Report (C.1.3) = (1 (Spontaneous) or 2 (Report from Study)) then Observation Code: (Value allowed: 1, 6) respectively.",ü,,R0016,FDA.C.1.7.1 must have Observation Code Value of 1 or 6 when C.1.7 = true and C.1.3 = 1 or 2,,
C.1.8.1,Worldwide Unique Case Identification,,,,,,,
C.1.8.2,First Sender of This Case,,,,,,,
C.1.9.1 ,Other Case Identifiers in Previous Transmissions,,,,,,,
(Header),Source(s) of the Case Identifier(s) (repeat as necessary),,,,,,,
C.1.9.1.r.1 ,Source(s) of the Case Identifier,If Other Case Identifiers in Previous Transmissions (C.1.9.1) = True then Source(s) of the Case Identifier (C.1.9.1.r.1) cannot be empty,ü,,R0017,At least one C.1.9.1.r.1 must be provided when C.1.9.1 = true,,
C.1.9.1.r.2 ,Case Identifier(s),If Other Case Identifiers in Previous Transmissions (C.1.9.1) = True and Source(s) of the Case Identifier (C.1.9.1.r.1) is available then Case Identifier(s) (C.1.9.1.r.2) cannot be empty,ü,,R0018,C.1.9.1.r.2 must be provided for C.1.9.1.r.1 = <value>,,
(Header),Identification Number of the Report Which Is Linked to This Report (repeat as necessary),,,,,,,
C.1.10.r ,Identification Number of the Report Which Is Linked to This Report ,"For premarket ICSRs
If Patient (name or initials) (D.1) = AGGREGRATE, then Identification Number of the Report Which Is Linked to This Report (C.1.10.r ) should be provided for all Sender’s (case) Safety Report Unique Identifier (C.1.1) that makes up an Aggregate Analysis as per 312.32(c)(1)(i)(C) whether previously sent to FAERS or to eCTD (use Manufacturer Control Number (MCN))",,ü,W0001,"C.1.10.r should be provided when D.1 = ""AGGREGRATE""",,
C.1.11.1 ,Report Nullification / Amendment,,ü,,R0101,C.1.11.1 must not have the value (1 or 2) for an initial report,,
C.1.11.2 ,Reason for Nullification / Amendment,"Optional, but required when C.1.11.1 is populated.",ü,,,C.1.11.2 must be  provided when C.1.11.1 is provided ,,
FDA.C.1.12,Combination Product Report Indicator,,,,,,,
(Header),Primary Source(s) of Information (repeat as necessary),,,,,,,
(Header),Reporter's Name,,,,,,,
C.2.r.1.1,Reporter’s Title,,,,,,,
C.2.r.1.2 ,Reporter’s Given Name,,,,,,,
C.2.r.1.3 ,Reporter’s Middle Name,,,,,,,
C.2.r.1.4 ,Reporter’s Family Name,,,,,,,
(Header),Reporter's Address and Telephone,,,,,,,
C.2.r.2.1 ,Reporter’s Organisation,,,,,,,
C.2.r.2.2 ,Reporter’s Department,,,,,,,
C.2.r.2.3 ,Reporter’s Street,,,,,,,
C.2.r.2.4 ,Reporter’s City,,,,,,,
C.2.r.2.5,Reporter’s State or Province,,,,,,,
FDA.C.2.r.2.5.1,Reporter's County,,,,,,,
C.2.r.2.6 ,Reporter’s Postcode,,,,,,,
C.2.r.2.7 ,Reporter’s Telephone,,,,,,,
FDA.C.2.r.2.8,Reporter's Email,,,,,,,
C.2.r.3 ,Reporter’s Country Code,"Optional, but required if C.2.r.5 = 1.",ü,,R0019,C.2.r.3 must be provided when C.2.r.5 = 1,,
C.2.r.4,Qualification,"Optional, but required if C.2.r.5 = 1.",ü,,R0020,C.2.r.4 must be provided when C.2.r.5 = 1,,
C.2.r.5 ,Primary Source for Regulatory Purposes,,ü,,R0021,At least one reporter must be provided with C.2.r.5 = 1 ,,
(Header),Information on Sender of Case Safety Report,,,,,,,
C.3.1 ,Sender Type,,,,,,,
C.3.2 ,Sender’s Organisation,Required if the ‘Sender Type’ (C.3.1) is not coded as 7 (Patient / Consumer).,ü,,R0022,"C.3.2 must be provided when C.3.1 = 1, 2, 3, 4, 5 or 6",,
(Header),Person Responsible for Sending Report,,,,,,,
C.3.3.1 ,Sender’s Department,,,,,,,
C.3.3.2,Sender’s Title,,,,,,,
C.3.3.3 ,Sender’s Given Name,,,,,,,
C.3.3.4 ,Sender’s Middle Name,,,,,,,
C.3.3.5 ,Sender’s Family Name,,,,,,,
(Header),"Sender's Address, Fax, Telephone and E-mail Address",,,,,,,
C.3.4.1,Sender’s Street Address,,,,,,,
FDA.C.3.4.1.1,Sender's Street Address line 2,,,,,,,
C.3.4.2 ,Sender’s City,,,,,,,
C.3.4.3 ,Sender’s State or Province,,,,,,,
C.3.4.4 ,Sender’s Postcode,,,,,,,
C.3.4.5 ,Sender’s Country Code,,,,,,,
C.3.4.6 ,Sender’s Telephone,,,,,,,
C.3.4.7,Sender’s Fax,,,,,,,
C.3.4.8 ,Sender’s E-mail Address,,,,,,,
(Header), Literature Reference(s) (repeat as necessary),,,,,,,
C.4.r.1 ,Literature Reference(s),,,,,,,
C.4.r.2 ,Included Documents,,,,,,,
(Header),Study Identification,,,,,,,
(Header),Study Registration (repeat as necessary),,,,,,,
C.5.1.r.1,Study Registration Number,,,,,,,
C.5.1.r.2 ,Study Registration Country,,,,,,,
C.5.2 ,Study Name,,,,,,,
C.5.3,Sponsor Study Number,,,,,,,
C.5.4,Study Type Where Reaction(s) / Event(s) Were Observed,"Optional, but required if C.1.3=2(Report from study)",ü,,R0023,C.5.4 must be provided when C.1.3 =2,,
,,"If Type of Report (C.1.3) is 2 (Report from Study) and Message Receiver Identifier (N.2.r.3) = 'CDER_IND' or 'CBER_IND' or 'CDER_IND_EXEMPT_BA_BE' and Batch Receiver Identifier (N.1.4) = 'ZZFDA_PREMKT' then Observation Code: (Value allowed: 1, 2, 3) for Study Type Where Reaction(s) / Event(s) Were Observed (C.5.4)",ü,,R0102,"C.5.4 must be 1, 2 or 3 when C.1.3 = 2 and N.2.r.3 = ""CDER_IND"" or ""CBER_IND"" or ""CDER_IND_EXEMPT_BA_BE"" and N.1.4 = ""ZZFDA_PREMKT""",,
,,If Type of Report (C.1.3) is 1 (Spontaneous) and Message Receiver Identifier (N.2.r.3) = 'CDER' then Study Type Where Reaction(s) / Event(s) Were Observed must not be provided,ü,,R0103,"C.5.4 must not be provided when C.1.3 = 1 and N.2.r.3 = ""CDER"" ",,
,,"If Type of Report (C.1.3) is 2 (Report from Study) and Message Receiver Identifier (N.2.r.3) = 'CDER' and Batch Receiver Identifier (N.1.4) = 'ZZFDA' then Observation Code: (Value allowed: 1, 2, 3) for Study Type Where Reaction(s) / Event(s) Were Observed (C.5.4)",ü,,R0104,"C.5.4 must be 1 or 2 or 3 when C.1.3 = 2, N.2.r.3 = ""CDER"" and N.1.4 = 'ZZFDA'",,
,,If Type of Report (C.1.3) is 1 (Spontaneous) and Batch Receiver Identifier (N.1.4) = ZZFDA_PREMKT and Message Receiver Identifier (N.2.r.3) = 'CDER_IND' or 'CBER_IND' then C.5.4 must not be provided.,ü,,R0113,"C.5.4 must not be provided when N.1.4 = ""ZZFDA_PREMKT"" and N.2.r.3 = 'CDER_IND' or 'CBER_IND' and C.1.3 =1 ",,
,,"If Patient (name or initials) (D.1) = AGGREGRATE, then Observation Code: (Value allowed: 1) for Study Type Where Reaction(s) / Event(s) Were Observed (C.5.4)",,ü,W0002,"C.5.4 should be 1 when D.1 = ""AGGREGRATE""",,
FDA.C.5.5a,IND Number where AE Occurred,"If Type of Report (C.1.3) is (1=Spontaneous or 2=Report from study) and Message Receiver Identifier (N.2.r.3) = 'CDER_IND' or 'CBER_IND' then IND Number where AE Occurred (FDA.C.5.5a) is required. The format must be ""123456"".  

For IND safety reports submitted from an aggregate analysis (312.32(c)(1)(i)(C)) from trials conducted under more than one IND, use the “Parent” IND number",ü,,R0024,"FDA.C.5.5a must be provided when C.1.3 = (1 or 2) and N.2.r.3 = ""CDER_IND"" or ""CBER_IND"" ",,
,,IND Number where AE Occurred (FDA.C.5.5a) must not be provided for a postmaket report.,ü,,R0107,"FDA.C.5.5a must not be provided when N.2.r.3 = ""CDER"" or ""CBER"" and N.1.4 = ""ZZFDA""",,
,,The IND Number where AE Occurred (FDA.C.5.5a) must be a valid number registered with the FDA. ,ü,,R0105,FDA.C.5.5a is invalid for the Center specified in N.2.r.3,,
FDA.C.5.5b,Pre-ANDA Number where AE Occurred,"If Type of Report (C.1.3) is 2=Report from study and Message Receiver Identifier (N.2.r.3) = 'CDER_IND_EXEMPT_BA_BE' then Pre-ANDA Number where AE Occurred (FDA.C.5.5b) is required. The format must be ""234567"" for IND-exempt BA/BE study.",ü,,R0025,"FDA.C.5.5b must be provided when C.1.3 = 2 and N.2.r.3 = ""CDER_IND_EXEMPT_BA_BE""",,
,,The Pre-ANDA Number where AE Occurred (FDA.C.5.5b) must not be provided for a postmarket report. ,ü,,R0108,"FDA.C.5.5b must not be provided when N.2.r.3 = ""CDER"" or ""CBER"" and N.1.4 = ""ZZFDA""",,
,,The Pre-ANDA Number where AE Occurred (FDA.C.5.5b) must be a valid number registered with the FDA. ,ü,,R0106,FDA.C.5.5b is invalid for the Center specified in N.2.r.3,,
FDA.C.5.6.r,IND number of cross reported IND,"If IND Number where AE Occurred (FDA.C.5.5a) is populated, then IND number of cross reported IND (FDA.C.5.6.r) is required. Use nullFlavor=NA if there are no other cross reported IND",ü,,R0026,FDA.C.5.6.r is not provided or nullFlavor is not 'NA' when FDA.C.5.5a is provided,,
,,The IND Number where AE Occurred (FDA.C.5.6.r) must not be provided for a postmarket report.,ü,,R0109,"FDA.C.5.6.r must not be provided when N.2.r.3 = ""CDER"" or ""CBER"" and N.1.4 = ""ZZFDA""",,
,,IND number of cross reported IND (FDA.C.5.6.r) must be a valid number registered with the FDA.,,ü,W0012,FDA.C.5.6.r is invalid for the Center specified in N.2.r.3,,
(Header),Patient Characteristics,,,,,,,
D.1 ,Patient (name or initials),"For postmarket ICSRs
The element must use nullFlavor ""NA"" where no patient is involved. (e.g. Medication error, Compounding)

For combination product, if a single report is reported for a malfunction without an adverse event, the element value must use nullFlavor ""NA"".

For combination product, if there are multiple malfunction reports with no adverse event, then the element value should be “SUMMARY”.",ü,,R0027,D.1 must be nullFlavor 'NA' when  FDA.C.1.12 = true and FDA.G.k.12.r.1 = true and E.i.2.1b = 10067482,,
,,"For premarket ICSRs
For Aggregate Report, the element value must be “AGGREGATE”. 
If Type of Report (C.1.3) = 2 (Report from study) and Identification Number of the Report Which Is Linked to This Report (C.1.10.r ) and IND Number where AE Occurred (FDA.C.5.5a) is populated, then Patient (name or initials) (D.1) must have the value  'AGGREGATE'",,ü,W0010,"D.1 value must be ""AGGREGATE"" when C.1.3=2 and C.1.10.r and FDA.C.5.5a is provided ",,
D.1.1.1 ,Patient Medical Record Number(s) and Source(s) of the Record Number (GP Medical Record Number),,,,,,,
D.1.1.2 ,Patient Medical Record Number(s) and Source(s) of the Record Number (Specialist Record Number),,,,,,,
D.1.1.3 ,Patient Medical Record Number(s) and Source(s) of the Record Number (Hospital Record Number),,,,,,,
D.1.1.4 ,Patient Medical Record Number(s) and Source(s) of the Record Number (Investigation Number),,,,,,,
(Header),Age Information,,,,,,,
D.2.1,Date of Birth,,,,,,,
(Header),Age at time of Onset of Reaction / Event,,,,,,,
D.2.2a ,Age at Time of Onset of Reaction / Event (number),"Optional, but required if D.2.2b is populated.",ü,,R0029,D.2.2a must be provided when D.2.2b is provided,,
D.2.2b,Age at Time of Onset of Reaction / Event (unit),"Optional, but required if D.2.2a is populated.",ü,,R0030,D.2.2b  must be provided when D.2.2a is provided,,
D.2.2.1a ,Gestation Period When Reaction / Event Was Observed in the Foetus (number),"Optional, but required if D.2.2.1b is populated.",ü,,R0031,D.2.2.1a must be provided when D.2.2.1b is provided,,
D.2.2.1b ,Gestation Period When Reaction/Event Was Observed in the Foetus (unit),"Optional, but required if D.2.2.1a is populated.",ü,,R0032,D.2.2.1b must be provided when D.2.2.1a is provided,,
D.2.3,Patient Age Group (as per reporter),,,,,,,
D.3,Body Weight (kg),,,,,,,
D.4 ,Height (cm),,,,,,,
D.5 ,Sex,,,,,,,
D.6 ,Last Menstrual Period Date,,,,,,,
(Header),Structured Information on Relevant Medical History (repeat as necessary),,,,,,,
D.7.1.r.1a ,MedDRA Version for Medical History,"Optional, but required if D.7.1.r.1b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0033,D.7.1.r.1a must be provided when D.7.1.r.1b is provided for D.7.1.r.1b = <value>,,
D.7.1.r.1b,Medical History (disease / surgical procedure / etc.) (MedDRA code),"Optional, but required if D.7.1.r.1a is populated.",ü,,R0034,D.7.1.r.1b must be provided when D.7.1.r.1a is provided,,
D.7.1.r.2 ,Start Date,,,,,,,
D.7.1.r.3 ,Continuing,,,,,,,
D.7.1.r.4 ,End Date,,,,,,,
D.7.1.r.5 ,Comments,,,,,,,
D.7.1.r.6 ,Family History,,,,,,,
D.7.2 ,Text for Relevant Medical History and Concurrent Conditions (not including reaction / event),"Optional, but required if Section D.7.1 is null.",ü,,R0035,D.7.2 must be provided when no information is provided in Section D.7.1 ,,
D.7.3 ,Concomitant Therapies,,,,,,,
(Header),Relevant Past Drug History (repeat as necessary),,,,,,,
D.8.r.1 ,Name of Drug as Reported,"Optional, but required by the schema if any data element in section D.8.r
is used.",ü,,R0036,D.8.r.1 must be provided when any other information is provided in Section D.8.r,,
D.8.r.2a ,MPID Version Date / Number,,,,,,,
D.8.r.2b ,Medicinal Product Identifier (MPID),,,,,,,
D.8.r.3a ,PhPID Version Date/Number,,,,,,,
D.8.r.3b ,Pharmaceutical Product Identifier (PhPID),,,,,,,
D.8.r.4 ,Start Date,,,,,,,
D.8.r.5 ,End Date,,,,,,,
D.8.r.6a ,MedDRA Version for Indication,"Optional, but required if D.8.r.6b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0037,D.8.r.6a must be provided when D.8.r.6b is provided with value = <value>,,
D.8.r.6b ,Indication (MedDRA code),"Optional, but required if D.8.r.6a is populated.",ü,,R0038,D.8.r.6b must be provided when D.8.r.6a is provided,,
D.8.r.7a ,MedDRA Version for Reaction,"Optional, but required if D.8.r.7b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0039,D.8.r.7a must be provided when D.8.r.7b is provided with value = <value>,,
D.8.r.7b,Reaction (MedDRA code),"Optional, but required if D.8.r.7a is populated.",ü,,R0040,D.8.r.7b must be provided when D.8.r.7a is provided,,
(Header),In Case of Death,,,,,,,
D.9.1 ,Date of Death,"For premarket ICSRs, if Results in Death (E.i.3.2a) is ture then Date of Death is required.",ü,,R0041,"D.9.1 must be provided when C.1.3 = 2 and N.2.r.3 = ""CDER_IND"" or ""CBER_IND"" and E.i.3.2a = ture ",,
(Header), Reported Cause(s) of Death (repeat as necessary),,,,,,,
D.9.2.r.1a ,MedDRA Version for Reported Cause(s) of Death,"Optional, but required if D.9.2.r.1b is populated. Only 1 MedDRA version is allowed per ICSR. For MedDRA version 15.1 value allowed is '15.1'. ",ü,,R0042,D.9.2.r.1a must be provided when D.9.2.r.1b is provided with value = <value>,,
D.9.2.r.1b ,Reported Cause(s) of Death (MedDRA code),"Optional, but required if D.9.2.r.1a is populated.",ü,,R0043,D.9.2.r.1b must be provided when D.9.2.r.1a is provided,,
D.9.2.r.2,Reported Cause(s) of Death (free text),"Optional, but required if D.9.2.r.1 is populated.",ü,,R0044,D.9.2.r.2 must be provided when D.9.2.r.1a and D.9.2.r.1b is provided,,
D.9.3 ,Was Autopsy Done?,"Optional, but required if D.9.1 is populated
Please see section 3.3.6 for further guidance on the use of nullFlavor to describe missing or non-transmitted information.",ü,,R0045,D.9.3 must be provided when D.9.1 is provided,,
(Header),Autopsy-determined Cause(s) of Death (repeat as necessary),,,,,,,
D.9.4.r.1a ,MedDRA Version for Autopsy-determined Cause(s) of Death,"Optional, but required if D.9.4.r.1b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0046,D.9.4.r.1a must be provided when D.9.4.r.1b is provided with value = <value>,,
D.9.4.r.1b,Autopsy-determined Cause(s) of Death (MedDRA code),"Optional, but required if D.9.4.r.1a is populated.",ü,,R0047,D.9.4.r.1b must be provided when D.9.4.r.1a is  provided,,
D.9.4.r.2 ,Autopsy-determined Cause(s) of Death (free text),"Optional, but required if D.9.4.r.1 is populated.",ü,,R0048,D.9.4.r.2 must be provided when D.9.4.r.1a and D.9.4.r.1b is provided,,
(Header),"For a Parent-Child / Foetus Report, Information Concerning The Parent",,,,,,,
D.10.1 ,Parent Identification,,,,,,,
(Header),Parent Age Information,,,,,,,
D.10.2.1,Date of Birth of Parent,,,,,,,
D.10.2.2a ,Age of Parent (number),"Optional, but required if D.10.2.2b is populated.",ü,,R0049,D.10.2.2a must be provided when D.10.2.2b is provided,,
D.10.2.2b ,Age of Parent (unit),"Optional, but required if D.10.2.2a is populated.",ü,,R0050,D.10.2.2b must be provided when D.10.2.2a is provided,,
D.10.3 ,Last Menstrual Period Date of Parent,,,,,,,
D.10.4 ,Body Weight (kg) of Parent,,,,,,,
D.10.5 ,Height (cm) of Parent,,,,,,,
D.10.6,Sex of Parent,"Required, if any data element in D.10 section is populated.",ü,,R0051,D.10.6 must be provided when any information is provided in Section D.10,,
(Header),Relevant Medical History and Concurrent Conditions of Parent,,,,,,,
(Header),Structured Information of Parent (repeat as necessary),,,,,,,
D.10.7.1.r.1a,MedDRA Version for Medical History,"Optional, but required if D.10.7.1.r.1b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0052,D.10.7.1.r.1a must be provided when D.10.7.1.r.1b is provided with value = <value>,,
D.10.7.1.r.1b ,Medical History (disease / surgical procedure / etc.) (MedDRA code),"Optional, but required if D.10.7.1.r.1a is populated.",ü,,R0053,D.10.7.1.r.1b must be provided when D.10.7.1.r.1a is provided,,
D.10.7.1.r.2 ,Start Date,,,,,,,
D.10.7.1.r.3 ,Continuing,,,,,,,
D.10.7.1.r.4 ,End Date,,,,,,,
D.10.7.1.r.5 ,Comments,,,,,,,
D.10.7.2 ,Text for Relevant Medical History and Concurrent Conditions of Parent,,,,,,,
(Header),Relevant Past Drug History of Parent (repeat as necessary),,,,,,,
D.10.8.r.1 ,Name of Drug as Reported,,,,,,,
D.10.8.r.2a ,MPID Version Date / Number,,,,,,,
D.10.8.r.2b ,Medicinal Product Identifier (MPID),,,,,,,
D.10.8.r.3a ,PhPID Version Date/Number,,,,,,,
D.10.8.r.3b ,Pharmaceutical Product Identifier (PhPID),,,,,,,
D.10.8.r.4 ,Start Date,,,,,,,
D.10.8.r.5 ,End Date,,,,,,,
D.10.8.r.6a ,MedDRA Version for Indication,"Optional, but required if D.10.8.r.6b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0054,D.10.8.r.6a must be provided when D.10.8.r.6b is provided with value = <value>,,
D.10.8.r.6b ,Indication (MedDRA code),"Optional, but required if D.10.8.r.6a is populated.",ü,,R0055,D.10.8.r.6b must be provided when D.10.8.r.6a is provided,,
D.10.8.r.7a ,MedDRA Version for Reaction,"Optional, but required if D.10.8.r.7b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0056,D.10.8.r.7a must be provided when D.10.8.r.7b is provided with value = <value>,,
D.10.8.r.7b ,Reactions (MedDRA code),"Optional, but required if D.10.8.r.7a is populated.",ü,,R0057,D.10.8.r.7b must be provided when D.10.8.r.7a is provided,,
FDA.D.11.r,Patient Race Code,"Appropriate nullFlavor must be used if FDA.D.11.r (Patient Race Code) is not reportable.

If Patient (name or initials) (D.1) is nullFlavor ""NA"" or ""SUMMARY"" then use nullFlavor: NA

If Patient (name or initials) (D.1) is ""AGGREGATE""  then use nullFlavor: NA",,ü,W0003,"FDA.D.11.r should be provided as nullFlavor ""NA"" when D.1 is provided as nullFlavor ""NA"" or ""SUMMARY"" or ""AGGREGRATE""",,
FDA.D.12,Patient Ethnicity Code,"Appropriate nullFlavor must be used if FDA.D.12 (Patient Ethnicity Code) is not reportable.

If Patient (name or initials) (D.1) is nullFlavor ""NA"" or ""SUMMARY"" then use nullFlavor: NA

If Patient (name or initials) (D.1) is ""AGGREGATE""  then use nullFlavor: NA",,ü,W0004,"FDA.D.12 should be provided as nullFlavor ""NA"" when D.1 is provided as nullFlavor ""NA"" or ""SUMMARY"" or ""AGGREGRATE""",,
(Header),Reaction/Event as Reported by the Primary Source,,,,,,,
E.i.1.1a ,Reaction / Event as Reported by the Primary Source in Native Language,,,,,,,
E.i.1.1b ,Reaction / Event as Reported by the Primary Source Language,"Optional, but required if E.i.1.1a is populated.",ü,,R0058,E.i.1.1b must be provided when E.i.1.1a is provided,,
E.i.1.2 ,Reaction / Event as Reported by the Primary Source for Translation,,,,,,,
E.i.2.1a ,MedDRA Version for Reaction / Event,,,,,,,
E.i.2.1b ,Reaction / Event (MedDRA code),,,,,,,
E.i.3.1 ,Term Highlighted by the Reporter,,,,,,,
(Header),Seriousness Criteria at Event Level,,,,,,,
E.i.3.2a ,Results in Death,,,,,,,
E.i.3.2b ,Life Threatening,,,,,,,
E.i.3.2c ,Caused / Prolonged Hospitalisation,,,,,,,
E.i.3.2d ,Disabling / Incapacitating,,,,,,,
E.i.3.2e ,Congenital Anomaly / Birth Defect,,,,,,,
E.i.3.2f ,Other Medically Important Condition,,,,,,,
FDA.E.i.3.2h,Required Intervention,,,,,,,
E.i.4 ,Date of Start of Reaction / Event,,,,,,,
E.i.5 ,Date of End of Reaction / Event,,,,,,,
E.i.6a ,Duration of Reaction / Event (number),"Optional, but required if E.i.6b is populated.",ü,,R0059,E.i.6a must be provided when E.i.6b is provided,,
E.i.6b ,Duration of Reaction / Event (unit),"Optional, but required if E.i.6a is populated.",ü,,R0060,E.i.6b must be provided when E.i.6a is provided,,
E.i.7 ,Outcome of Reaction / Event at the Time of Last Observation,,,,,,,
E.i.8 ,Medical Confirmation by Healthcare Professional,,,,,,,
E.i.9 ,Identification of the Country Where the Reaction / Event Occurred,,,,,,,
(Header),Results of Tests and Procedures Relevant to the Investigation of the Patient (repeat as necessary),,,,,,,
F.r.1 ,Test Date,"Optional, but required if F.r.2 is populated.",ü,,R0061,F.r.1 must be provided when any of the data element in F.r.2 is provided,,
F.r.2.1 ,Test Name (free text),"Optional, but required if F.r.1 is populated and F.r.2.2b is not populated.",ü,,R0062,F.r.2.1 must be provided when F.r.1 is provided and F.r.2.2b is not provided ,,
F.r.2.2a ,MedDRA Version for Test Name,"Optional, but required when F.r.2.2b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0063,F.r.2.2a must be provided when F.r.2.2b is provided with value = <value>,,
F.r.2.2b ,Test Name (MedDRA code),"Optional, but required when F.r.1 is populated and F.r.2.1 is not populated.",ü,,R0064,F.r.2.2b must be provided when F.r.1 is provided and F.r.2.1 is not provided,,
(Header),Test Result,,,,,,,
F.r.3.1 ,Test Result (code),"Optional, but required if F.r.2 is populated, and neither F.r.3.2 nor F.r.3.4 is populated. This data element can be used when a numeric value cannot describe the result.",ü,,R0065,"At least one of test results (F.r.3.1, F.r.3.2, F.r.3.4) must contain a value when F.r.2.2b is provided.",,
F.r.3.2 ,Test Result (value / qualifier),"Optional, but required if F.r.2 is populated, and F.r.3.1 and F.r.3.4 is not populated. If results and units cannot be split, F.r.3.4 should be used.",ü,,R0066,"At least one of test results (F.r.3.1, F.r.3.2, F.r.3.4) must contain a value when F.r.2.2b is provided.",,
F.r.3.3 ,Test Result (unit),"Optional, but required if F.r.3.2 is populated. Constrained UCUM is not provided for this unit.  Select most appropriate unit from UCUM codes. ",ü,,R0067,F.r.3.3 must be provided when F.r.3.2 is provided,,
F.r.3.4,Result Unstructured Data (free text),"Optional, but required if F.r.2 is populated, and F.r.3 is not populated.",ü,,R0068,"At least one of test results (F.r.3.1, F.r.3.2, F.r.3.4) must contain a value when F.r.2.2b is provided.",,
F.r.4 ,Normal Low Value,,,,,,,
F.r.5 ,Normal High Value,,,,,,,
F.r.6 ,Comments (free text),,,,,,,
F.r.7 ,More Information Available,,,,,,,
(Header),Drug(s) Information (repeat as necessary),,,,,,,
G.k.1 ,Characterisation of Drug Role,"For postmarket ICSRs
The first product (under section G) should have this data element answered as ‘1’ (=Suspect) or ‘3’ (=Interacting), unless the product has at least once device constituent part where Malfunction (FDA.G.k.12.r.1) is “true”, in which case the Observation Code: (Value allowed: 1, 3, 4)",,ü,W0005,"The first product reported does not have G.k.1 with Observation Code Value of 1, 3 or 4.",,
,,"For postmarket ICSRs
At least one product must be reported with Observation Code: (Value allowed: 1, 3, 4)",ü,,R0069,"G.k.1 must be provided with Observation Code Value of 1, 3 or 4 when N.2.r.3 = ""CDER"" ",,
,,"For premarket ICSRs
For IND ICSRs, Only use Observation Code: (Value allowed: 1, 2, 3) and at least one product must be reported with Observation Code: (Value allowed: 1, 3)",ü,,R0070,"G.k.1 must be provided with Observation Code Value of 1 or 3 when C.1.3 = 2 and N.2.r.3 = ""CDER_IND"" or ""CBER_IND""",,
,,"
For IND-exempt BA/BE ICSRs, Use Observation Code: (Value allowed: 1, 2, 3, 4) and at least one product must be reported with Observation Code: (Value allowed: 1, 3, 4)",ü,,R0071,"G.k.1 must be provided with Observation Code Value of 1, 3 or 4 when C.1.3 = 2 and N.2.r.3 = ""CDER_EXEMPT_BA_BE""",,
FDA.G.k.1.a,FDA Other Characterisation of Drug Role,"For Similar Device Observation Code: (Value allowed: 1) is only allowed if Combination Product Report Indicator (FDA.C.1.12) is 'true', Malfunction (FDA.G.k.12.r.1) is 'true' and Characterisation of Drug Role (G.k.1) = '4' (Drug Not Administered) under 21 CFR 4.102(c) and 803.50",ü,,R0072,G.k.1.a must be provided when FDA.C.1.12 = true and FDA.G.k.12.r. = true' and G.k.1 = 4  is provided,,
(Header),Drug Identification,,,,,,,
G.k.2.1.1a ,MPID Version Date / Number,,,,,,,
G.k.2.1.1b ,Medicinal Product Identifier (MPID) ,,,,,,,
G.k.2.1.2a,PhPID Version Date/Number,,,,,,,
G.k.2.1.2b ,Pharmaceutical Product Identifier (PhPID),,,,,,,
G.k.2.2 ,Medicinal Product Name as Reported by the Primary Source,"For premarket ICSRs, Medicinal Product Name as Reported by the Primary Source (G.k.2.2) does not match the product name for the application number provided in IND Number where AE Occurred (FDA.C.5.5a) or Pre-ANDA Number where AE Occurred (FDA.C.5.5b)   ",,ü,W0009,G.k.2.2 does not match the registered product name for application# reported in FDA.C.5.5a/FDA.C.5.5b. Ignore this message for comparator study product.,,
FDA.G.k.2.2.1,U.S. generic name,,,,,,,
(Header),Substance / Specified Substance Identifier and Strength (repeat as necessary),,,,,,,
G.k.2.3.r.1 ,Substance / Specified Substance Name,,,,,,,
G.k.2.3.r.2a ,Substance/Specified Substance TermID Version Date/Number,,,,,,,
G.k.2.3.r.2b ,Substance/Specified Substance TermID,,,,,,,
G.k.2.3.r.3a ,Strength (number) ,,,,,,,
G.k.2.3.r.3b ,Strength (unit),"Optional, but required if G.k.2.3.r.3a is populated.",ü,,R0073,G.k.2.3.r.3b must be provided when G.k.2.3.r.3a is provided,,
G.k.2.4,Identification of the Country Where the Drug Was Obtained,,,,,,,
G.k.2.5 ,Investigational Product Blinded,,,,,,,
G.k.3.1 ,Authorisation / Application Number,"Authorisation / Application Number (G.K.3.1) should not contain “IND” or “PANDA” number when Batch Receiver Identifier (N.1.4) = “ZZFDA” and Message Receiver Identifier (N.2.r.3) = ""CDER"" and Type of Report (C.1.3) = 2 and Study Type Where Reaction(s) / Event(s) Were Observed (C.5.4) = 2 or 3",ü,,R0114,"G.K.3.1 should not contain “IND” or “PANDA” number when N.1.4 = “ZZFDA” and N.2.r.3 = ""CDER"" and C.1.3=2 and C.5.4=2 or 3",,
G.k.3.2 ,Country of Authorisation / Application,"Optional, but required if G.k.3.1 is provided.",ü,,R0074,G.k.3.2 must be provided when G.k.3.1 is provided,,
G.k.3.3 ,Name of Holder / Applicant,,,,,,,
(Header),Dosage and Relevant Information (repeat as necessary),,,,,,,
G.k.4.r.1a ,Dose (number),,,,,,,
G.k.4.r.1b ,Dose (unit),"Optional, but required if G.k.4.r.1a is populated.",ü,,R0075,G.k.4.r.1b must be provided when G.k.4.r.1a is provided,,
G.k.4.r.2 ,Number of Units in the Interval,,,,,,,
G.k.4.r.3 ,Definition of the Time Interval Unit,"Optional, but required if G.k.4.r.2 is populated.",ü,,R0076,G.k.4.r.3 must be provided when G.k.4.r.2 is provided,,
G.k.4.r.4,Date and Time of Start of Drug,,,,,,,
G.k.4.r.5 ,Date and Time of Last Administration,,,,,,,
G.k.4.r.6a ,Duration of Drug Administration (number),"Optional, but required if G.k.4.r.6b is populated.",ü,,R0077,G.k.4.r.6a must be provided when G.k.4.r.6b is provided,,
G.k.4.r.6b ,Duration of Drug Administration (unit),"Optional, but required if G.k.4.r.6a is populated.",ü,,R0078,G.k.4.r.6b must be provided when G.k.4.r.6a is provided,,
G.k.4.r.7 ,Batch / Lot Number,,,,,,,
G.k.4.r.8 ,Dosage Text,,,,,,,
G.k.4.r.9.1 ,Pharmaceutical Dose Form (free text),,,,,,,
G.k.4.r.9.2a ,Pharmaceutical Dose Form TermID Version Date/Number,,,,,,,
G.k.4.r.9.2b,Pharmaceutical Dose Form TermID,,,,,,,
G.k.4.r.10.1 ,Route of Administration (free text),,,,,,,
G.k.4.r.10.2a,Route of Administration TermID Version Date / Number,,,,,,,
G.k.4.r.10.2b ,Route of Administration TermID,,,,,,,
G.k.4.r.11.1 ,Parent Route of Administration (free text),,,,,,,
G.k.4.r.11.2a ,Parent Route of Administration TermID Version Date / Number,,,,,,,
G.k.4.r.11.2b ,Parent Route of Administration TermID,,,,,,,
G.k.5a ,Cumulative Dose to First Reaction (number),"Optional, but required if G.k.5b is populated.",ü,,R0079,G.k.5a must be provided when G.k.5b is provided,,
G.k.5b ,Cumulative Dose to First Reaction (unit),"Optional, but required if G.k.5a is populated.",ü,,R0080,G.k.5b must be provided when G.k.5a is provided,,
G.k.6a ,Gestation Period at Time of Exposure (number),"Optional, but required if G.k.6b is populated.",ü,,R0081,G.k.6a must be provided when G.k.6b is provided,,
G.k.6b ,Gestation Period at Time of Exposure (unit),"Optional, but required if G.k.6a is populated.",ü,,R0082,G.k.6b must be provided when G.k.6a is provided,,
(Header),Indication for Use in Case (repeat as necessary),,,,,,,
G.k.7.r.1 ,Indication as Reported by the Primary Source,,,,,,,
G.k.7.r.2a ,MedDRA Version for Indication,"Optional, but required if G.k.7.r.2b is populated.
Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0083,G.k.7.r.2a must be provided when G.k.7.r.2b is provided,,
G.k.7.r.2b ,Indication (MedDRA code),"Optional, but required if G.k.7.r.2a is populated.
If nullFlavor is used in G.k.7.r.1, select an appropriate MedDRA term to reflect that the indication is not available.",ü,,R0084,G.k.7.r.2b must be provided when G.k.7.r.2a is provided,,
G.k.8 ,Action(s) Taken with Drug,,,,,,,
(Header),Drug-reaction(s) / Event(s) Matrix (repeat as necessary),,,,,,,
G.k.9.i.1 ,Reaction(s) / Event(s) Assessed,,,,,,,
(Header),Assessment of Relatedness of Drug to Reaction(s) / Event(s) (repeat as necessary),,,,,,,
G.k.9.i.2.r.1 ,Source of Assessment,"For premarket ICSRs
Required, if Element Value for Type of Report (C.1.3) is 2 (=Report from study) and IND Number where AE Occurred (FDA.C.5.5a) is provided.
Default Source of Assessment (G.k.9.i.2.r.1 ) to ""Sponsor"" ",ü,,R0085,G.k.9.i.2.r.1 must be provided when C.1.3 = 2 and FDA.C.5.5a is provided,,
G.k.9.i.2.r.2,Method of Assessment,"For premarket ICSRs
Required, if Element Value for Type of Report (C.1.3) is 2 (=Report from study) and IND Number where AE Occurred (FDA.C.5.5a) is provided.
Default Method of Assessment (G.k.9.i.2.r.2) to “FDA” to differentiate from other assessment methods.",ü,,R0086,G.k.9.i.2.r.2 must be provided when C.1.3 = 2 and FDA.C.5.5a is provided,,
G.k.9.i.2.r.3 ,Result of Assessment,"For premarket ICSRs
Required, if Element Value for Type of Report (C.1.3) is 2 (=Report from study) and IND Number where AE Occurred (FDA.C.5.5a) is provided
For IND Safety Reports, at least one suspect product should have relatedness of drug to reaction/event
For Result of Assessment (G.k.9.i.2.r.3) use the value ""Suspected"" or ""Not Suspected""",ü,,R0087,G.k.9.i.2.r.3 must be provided when C.1.3 = 2 and FDA.C.5.5a is provided,,
G.k.9.i.3.1a ,Time Interval between Beginning of Drug Administration and Start of Reaction / Event (number),"Optional, but required if G.k.9.i.3.1b is populated.",ü,,R0088,G.k.9.i.3.1a must be provided when G.k.9.i.3.1b is provided,,
G.k.9.i.3.1b ,Time Interval between Beginning of Drug Administration and Start of Reaction / Event (unit),"Optional, but required if G.k.9.i.3.1a is populated.",ü,,R0089,G.k.9.i.3.1b must be provided when G.k.9.i.3.1a is provided,,
G.k.9.i.3.2a ,Time Interval between Last Dose of Drug and Start of Reaction / Event (number),"Optional, but required if G.k.9.i.3.2b is populated.",ü,,R0090,G.k.9.i.3.2a must be provided when G.k.9.i.3.2b is provided,,
G.k.9.i.3.2b ,Time Interval between Last Dose of Drug and Start of Reaction / Event (unit),"Optional, but required if G.k.9.i.3.2a is populated.",ü,,R0091,G.k.9.i.3.2b must be provided when G.k.9.i.3.2a is provided,,
G.k.9.i.4 ,Did Reaction Recur on Re-administration?,,,,,,,
G.k.10.r ,Additional Information on Drug (coded) (repeat as necessary),,,,,,,
FDA.G.k.10a,FDA Additional Information on Drug (coded) (repeat as necessary),"If Pre-ANDA Number where AE Occurred (FDA.C.5.5b) is present, then the Observation Code: (Value allowed: 1, 2) must be used to describe the drug’s role in the IND-Exempt BA/BE study. Use nullFlavor 'NA' for all other drugs or if information is not available.",,ü,W0006,"FDA.G.k.10a should be provided with Observation Code value of 1, 2 or nullFlavor ""NA"" when FDA.C.5.5b is provided",,
FDA.G.k.10.1,FDA Specialized Product Category,,,,,,,
G.k.11 ,Additional Information on Drug (free text),,,,,,,
(Header),Device Information (repeat as necessary),,,,,,,
FDA.G.k.12.r.1,Malfunction,"For postmarket ICSRs
If Local Criteria Report Type (FDA.C.1.7.1) = 5, then Malfunction (FDA.G.k.12.r.1) must be 'true' for at least one suspect product",ü,,R0092,FDA.G.k.12.r.1 must be 'true' for at least one suspect product when FDA.C.1.7.1 = 5,,
FDA.G.k.12.r.2.r,"If follow-up, what type?",,,,,,,
FDA.G.k.12.r.3.r,Device Problem Code,"For postmarket ICSRs
Required, if Malfunction (FDA.G.k.12.r.1) is 'true'. FDA will only validate format. One or more codes can be provided.",ü,,R0093,FDA.G.k.12.r.3.r must be provided when FDA.G.k.12.r.1 = true ,,
,,"For postmarket ICSRs
Provide valid FDA or IMDRF device problem code ",,ü,W0008,FDA.G.k.12.r.3.r contain invalid value,,
FDA.G.k.12.r.4,Device Brand Name,"For postmarket ICSRs
If Combination Product Report Indicator (FDA.C.1.12) is true, then provide the  device brand name and the common device name. Either can be null however, if both are null a value for Device Product Code (FDA.G.k.12.r.6) is required ",ü,,R0094,FDA.G.k.12.r.4 and/or FDA.G.k.12.r.5 must be provided when FDA.C.1.12 = true,,
FDA.G.k.12.r.5,Common Device Name,"For postmarket ICSRs
If Combination Product Report Indicator (FDA.C.1.12) is true, then provide the  device brand name and the common device name. Either can be null however, if both are null a value for Device Product Code (FDA.G.k.12.r.6) is required ",ü,,R0095,FDA.G.k.12.r.4 and/or FDA.G.k.12.r.5 must be provided when FDA.C.1.12 = true,,
FDA.G.k.12.r.6,Device Product Code,"For postmarket ICSRs
If both Device Brand Name (FDA.G.k.12.r.4) and Common Device Name (FDA.G.k.12.r.5) are null, then the value for Device Product Code (FDA.G.k.12.r.6) is required",ü,,R0096,FDA.G.k.12.r.6 must be provided when FDA.G.k.12.r.4 and FDA.G.k.12.r.5 are not provided ,,
FDA.G.k.12.r.7,Device Manufacturer,,,,,,,
FDA.G.k.12.r.7.1a,Device Manufacturer Name,,,,,,,
FDA.G.k.12.r.7.1b,Manufacturer Address,,,,,,,
FDA.G.k.12.r.7.1c,Device Manufacturer City,,,,,,,
FDA.G.k.12.r.7.1d,Device Manufacturer State,,,,,,,
FDA.G.k.12.r.7.1e,Device Manufacturer Country,,,,,,,
FDA.G.k.12.r.8,Device Usage,,,,,,,
FDA.G.k.12.r.9,Device Lot Number,,,,,,,
FDA.G.k.12.r.10,Operator of the Device,,,,,,,
FDA.G.k.12.r.11.r,Remedial Action Initiated,"For postmarket ICSRs
Required, if Malfunction (FDA.G.k.12.r.1) is 'true' and Local Criteria Report Type (FDA.C.1.7.1) = 4 (5-Day). ",,ü,W0007,FDA.G.k.12.r.11.r should be provided when FDA.G.k.12.r.1 = true and FDA.C.1.7.1 = 4 (5-Day),,
(Header),Vaccines Given Within 4 Weeks Organizer ,,,,,,,
FDA.G2.k.1,Vaccine Type,,,,,,,
FDA.G2.k.2a,MPID Version Date / Number,,,,,,,
FDA.G2.k.2b,MPID ,,,,,,,
FDA.G2.k.3,Date Given,,,,,,,
FDA.G2.k.4a,Route of Administration TermID Version Date / Number,,,,,,,
FDA.G2.k.4b,Route of Administration TermID,,,,,,,
FDA.G2.k.5,Vaccine Anatomical Approach Site,,,,,,,
FDA.G2.k.6,Dose Number in Series,,,,,,,
FDA.G2.k.7,Lot Number,,,,,,,
FDA.G2.k.8,Manufacturer Name,,,,,,,
(Header),Narrative Case Summary and Further Information,,,,,,,
H.1 ,"Case Narrative Including Clinical Course, Therapeutic Measures, Outcome and Additional Relevant Information",,,,,,,
H.2 ,Reporter's Comments,,,,,,,
(Header),Sender's Diagnosis (repeat as necessary),,,,,,,
H.3.r.1a ,MedDRA Version for Sender's Diagnosis / Syndrome and / or Reclassification of Reaction / Event,"Optional, but required if H.3.r.1b is populated. Only 1 MedDRA version is allowed per ICSR.   For MedDRA version 15.1 value allowed is '15.1'.",ü,,R0097,H.3.r.1a must be provided when H.3.r.1b is provided,,
H.3.r.1b,Sender's Diagnosis / Syndrome and / or Reclassification of Reaction / Event (MedDRA code),"Optional, but required if H.3.r.1a is populated.",ü,,R0098,H.3.r.1b must be provided when H.3.r.1a is provided ,,
H.4 ,Sender's Comments,,,,,,,
(Header),Case Summary and Reporter’s Comments in Native Language (repeat as necessary),,,,,,,
H.5.r.1a ,Case Summary and Reporter’s Comments Text,,,,,,,
H.5.r.1b ,Case Summary and Reporter’s Comments Language,Required if H.5.r.1a is populated.,ü,,R0099,H.5.r.1b must be provided when H.5.r.1a is provided,,
